Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-25

Clinical Trial Update: Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

View source ↗

Summary

This clinical trial at University Hospital Basel is investigating antibodies that cross-react with autoantigens during primary Epstein-Barr virus infection and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Epstein-Barr Virus (EBV) Infection | Status: RECRUITING